| Identification | |
| Name: | AMPRENAVIR |
| Synonyms: | KVX-478; AGENERASE; 141W94; PROZEI; 141W94, KVX-478, Agenerase, Prozei,; Carbamic acid, (1S,2R)-3-(4-aminophenyl)sulfonyl(2-methylpropyl)amino-2-hydroxy-1-(phenylmethyl)propyl-, (3S)-tetrahydro-3-furanyl ester; Angenerase; Amprenavir & its intermediates(R&D) |
| CAS: | 161814-49-9 |
| Molecular Formula: | C25H35N3O6S |
| Molecular Weight: | 505.63 |
| InChI: | InChI=1/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.3 g/cm3 |
| Refractive index: | 1.61 |
| Solubility: | In water, 40 mg/l @ 25 deg C |
| Appearance: | off-white to pale yellow |
| Specification: |
Amprenavir ,its CAS NO. is 161814-49-9,the synonyms is (3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate ; (3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate ; (3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate ; 141W94 ; APV ; Agenerase ; DRG-0258 ; HSDB 7157 ; Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate ; UNII-5S0W860XNR ; VX 478 ; Vertex VX478 ; Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester ; Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))- . |
| Usage: | A selective HIV protease inhibitor. An analogue of Ritonavir |
| Safety Data | |
 |
|
